Ключевые слова:
ремоделирование левого желудочка; обратное ремоделирование; коронарное шунтирование; фиброз миокарда; эндотелиальная дисфункция; трёхмерная эхокардиография; эхокардиография.Библиографические ссылки
1. Frantz S., Hundertmark M.J., Schulz-Menger J., Bengel F.M., Bauersachs J. Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies // European Heart Journal. — 2022. — Vol. 43, № 27. — P. 2549–2561.
2. Marcos-Garcés V., et al. Left Ventricular Remodeling After Myocardial Infarction — Pathophysiology, Diagnostic Approach and Management During Cardiac Rehabilitation // PMC. — 2024.
3. Subclinical Inflammation in Ischemic Heart Disease and Its Role in the Transition to Heart Failure // Life. — 2026. — Vol. 16, № 5. — Art. 789.
4. Post-myocardial infarction fibrosis: Pathophysiology, examination, and intervention // Frontiers in Pharmacology. — 2023.
5. Hnat T., et al. Left ventricular reverse remodelling and its predictors in non-ischaemic cardiomyopathy // ESC Heart Failure. — 2022.
6. Left Ventricular Reverse Remodeling After Revascularization and Its Predictive Role for Survival // medRxiv. — 2023.
7. TIMP-1 in the prognosis of patients who underwent coronary artery bypass surgery: a 12-year follow-up study // Frontiers in Cardiovascular Medicine. — 2023.
8. Zhu Y., Pei L., Li N. Preoperative sST2 Levels Relate to Myocardial Remodeling and Cardiac Function Improvement After Cardiac Valve Surgery // ESC Heart Failure. — 2024. — Vol. 11, № 1. — P. 91–98.
9. A metabolomics study reveals potential plasma biomarkers for predicting post-infarction left ventricular remodeling: findings from the Meta-boLights database // Frontiers in Cardiovascular Medicine. — 2025.
10. Novel myocardial markers GADD45G and NDUFS5 identified by RNA-sequencing predict left ventricular reverse remodeling in advanced non-ischemic heart failure: a retrospective cohort study // BMC Cardiovascular Disorders. — 2020.
11. Karatolios K., Chatzis G., Holzendorf V., Störk S., Richter A., Binas D., Schieffer B., Pankuweit S. Galectin-3 as a Predictor of Left Ventricular Reverse Remodeling in Recent-Onset Dilated Cardiomyopathy // Disease Markers. — 2018. — Vol. 2018. — Art. 2958219.
12. Hanna A., Frangogiannis N.G. The Role of the TGF-β Superfamily in Myocardial Infarction // Frontiers in Cardiovascular Medicine. — 2019. — Vol. 6. — Art. 140.
13. Vani A., Schwartzbard A., Weintraub H.S. Biomarkers as Surrogates for Coronary Endothelial Dysfunction in Patients With Nonobstructive Coronary Artery Disease // Journal of the American Heart Association. — 2018. — Vol. 7, № 15. — Art. e010 166.
14. Exploring nitric oxide as a crucial prognostic biomarker of coronary artery disease // Science Direct. — 2023.
15. Echocardiographic assessment of left ventricular systolic function // Journal of Echocardiography (Springer). — 2018.
16. Left ventricular end-systolic volume is a reliable predictor of new-onset heart failure with preserved left ventricular ejection fraction // PMC. — 2020.
17. Left Ventricular Architecture, Long-Term Reverse Remodeling, and Clinical Outcome in Mild Heart Failure With Cardiac Resynchronization: Results From the REVERSE Trial // JACC: Heart Failure. — 2018.
18. Echocardiographic parameters of left ventricle remodeling in patients with reduced ejection fraction before and after coronary artery bypass grafting // ResearchGate. — 2021.
19. Clinical Applications of Speckle-Tracking Echocardiography in Heart Failure: From Diagnosis to Prognostication // PMC. — 2025.
20. Two-Dimensional Speckle Tracking Echocardiography Assessment of Left Ventricular Remodeling in Patients after Myocardial Infarction // International Archives of Cardiovascular Diseases. — 2020.
21. Three-dimensional echocardiographic assessment of left ventricular geometric changes following acute myocardial infarction // PMC. — 2023.